It is critical that ensuring people’s access to effective treatment for common infections is aligned with efforts to reduce the risk of emerging antimicrobial resistance. The Institute of Development Studies, a Future Health Systems partner, is influencing policy agendas to give greater focus on the need for the just and sustainable use of antimicrobials.
Authors
